News & media
ELEVAI Labs, Inc. Announces Laboratory Expansion Allowing Fivefold Increase in Product Manufacturing Capabilities
The Company’s state-of-the-art lab and office space mark the 3rd expansion in 2 years, readying the company for further scalability to mass produce its first two SKUs under the E-Series umbrella; ELEVAI enfinity™ and ELEVAI empower™. The expansion effectively increases the Company’s production capabilities by approximately 500% and allows for continued R&D on the next wave of medical aesthetic products the company is developing.
ELEVAI LABS, INC. Announces Appointment of Chris Kraneiss as Chief Commercial Officer
DAVIS, Calif., Aug. 17, 2022 /PRNewswire/ — ELEVAI LABS, INC., (“ELEVAI” or the “Company”) a science-based, data-driven regenerative aesthetic skincare company is pleased to announce the appointment of industry veteran Chris Kraneiss as Chief Commercial Officer. Mr. Kraneiss holds a proven track record of building successful medical aesthetic businesses within top globally recognized brands.
ELEVAI LABS, INC. IS PLEASED TO ANNOUNCE THE APPOINTMENT OF BRENDA BUECHLER AS CHIEF MARKETING AND BRAND ADVISOR
Ms. Buechler has an extensive and successful career that spans over 23 years in director and leadership roles at companies including Alastin Skincare and SkinMedica. Ms. Buechler’s previous roles have included sales (B2C, B2B, and online), branding, and strategic marketing in start-ups as well as large established brands. Brenda is highly adept at building brands and developing marketing and communications strategies that exceed expectations and drive revenue.
ELEVAI IS PLEASED TO ANNOUNCE IT HAS WON THE PEOPLES CHOICE AWARD AT THE 2022 OCTANE AESTHETICS TECH SUMMIT
Co-Founder and CEO, Jordan R. Plews, Ph.D., and his team were invited to present at this two-day event attended by hundreds of leaders in medicine, the aesthetic industry, and the business world to discuss innovative medical aesthetic technologies, as well as unmet clinical needs and new business opportunities.
ELEVAI LABS, INC. ANNOUNCES GLOBAL DISTRIBUTION PARTNERSHIP WITH PREMIER AESTHETIC DEVICE COMPANY DERMAPENWORLD
DAVIS, Calif., Jan. 21, 2022 /PRNewswire/ — ELEVAI LABS, INC., (“ELEVAI” or the “Company”) a biotech company leveraging the power of human stem cell exosomes to create next-generation topical skincare products, is pleased to announce that it has signed a non-exclusive global distributor and trademark license agreement with leading Australian headquartered aesthetic device company DermapenWorld™ (“Dermapen”).
2022 Aesthetics Tech Summit in Newport Beach, California
DAVIS, CALIFORNIA, Jan 06, 2022, ELEVAI LABS, INC., (“ELEVAI” or the “Company“) a biotech company leveraging the power of human stem cell exosomes to create next-generation topical skincare products, is pleased to announce that company co-founder and CEO, Jordan Plews, Ph.D., has been invited to present and speak at the 2022 Aesthetics Tech Summit on January 20 – 21 at the Balboa Bay Resort, 1221 West Coast Hwy, Newport Beach, CA 92663.
ELEVAI LABS, INC. Announces Launch of its E-SERIES Product Line
ELEVAI’s E-SERIES product line includes skincare formulations to support and enhance the results of in-office aesthetic procedures including micro-needling, laser resurfacing, microdermabrasion, and chemical peels. The E-SERIES products will be available only through selected dermatologists, plastic surgeons, and aestheticians in the United States.